Progression of Ebola therapeutics during the 2014-2015 outbreak

Keyphrases

• Ebola 100%
• Ebola Outbreak 100%
• Clinical Trials 66%
• Diseases Therapeutic 66%
• Experimental Drugs 66%
• Repurposing 66%
• Infectious Disease Outbreaks 66%
• Survivors 33%
• Therapeutic Strategies 33%
• Associated Morbidity 33%
• Infectious Diseases 33%
• Clinical Evaluation 33%
• Disease-associated 33%
• Drug Efficacy 33%
• Nonhuman Primate Model 33%
• Safety Study 33%
• Human Use 33%
• West Africa 33%
• Small Molecule Drugs 33%
• Effective Compounds 33%
• Fast-growing 33%
• Guinea 33%
• Resource-limited Settings 33%
• RNA-based 33%
• Sierra Leone 33%
• Convalescent Plasma 33%
• Liberia 33%
• Antibody Therapy 33%
• Drug Safety 33%
• Drug Selection 33%
• Recombinant Antibody 33%
• Ebola Virus Disease 33%
• Effective Mode 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Clinical Trial 30%
• Ebola Virus 30%
• Infection 20%
• Repurposing 20%
• Epileptic Absence 10%
• Epidemic 10%
• Recombinant Antibody 10%
• Ebola Virus Disease 10%